淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 7045人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302406, encodeId=d5c8130240630, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=AJH：治疗和未治疗的慢性淋巴细胞白血病患者的第二原发恶性肿瘤发生率对比, objectType=article, longId=218215, objectId=3d1e21821536, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d1e21821536, replyNumber=0, likeNumber=70, createdTime=2021-10-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d1e21821536, moduleTitle=AJH：治疗和未治疗的慢性淋巴细胞白血病患者的第二原发恶性肿瘤发生率对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d1e21821536)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302405, encodeId=d743130240594, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Prostate：淋巴细胞与单核细胞比例可预测临床显著性前列腺癌, objectType=article, longId=218123, objectId=e32a21812350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e32a21812350, replyNumber=0, likeNumber=102, createdTime=2021-10-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e32a21812350, moduleTitle=Prostate：淋巴细胞与单核细胞比例可预测临床显著性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e32a21812350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302404, encodeId=6fe013024046e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后, objectType=article, longId=218055, objectId=1a5821805589, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a5821805589, replyNumber=0, likeNumber=83, createdTime=2021-10-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a5821805589, moduleTitle=Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a5821805589)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302403, encodeId=f183130240374, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=HAEMATOLOGICA：接受阿卡拉布替尼单药治疗的慢性淋巴细胞白血病患者的心血管不良事件: 762例患者的汇总分析。, objectType=article, longId=218053, objectId=6f90218053de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f90218053de, replyNumber=0, likeNumber=71, createdTime=2021-10-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f90218053de, moduleTitle=HAEMATOLOGICA：接受阿卡拉布替尼单药治疗的慢性淋巴细胞白血病患者的心血管不良事件: 762例患者的汇总分析。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f90218053de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302402, encodeId=76df130240220, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nature Communications：脂肪细胞破坏急性淋巴细胞白血病的转化程序，有利于肿瘤的存活和持久性, objectType=article, longId=217372, objectId=c8ba21e372af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ba21e372af, replyNumber=0, likeNumber=72, createdTime=2021-09-22, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ba21e372af, moduleTitle=Nature Communications：脂肪细胞破坏急性淋巴细胞白血病的转化程序，有利于肿瘤的存活和持久性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ba21e372af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302401, encodeId=780b13024019c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=INT J LAB HEMATO：外周颗粒状淋巴细胞减少症和畸形白细胞增多症作为 COVID-19 的简单预后标志物, objectType=article, longId=217347, objectId=3d9421e3474e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d9421e3474e, replyNumber=0, likeNumber=69, createdTime=2021-09-21, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d9421e3474e, moduleTitle=INT J LAB HEMATO：外周颗粒状淋巴细胞减少症和畸形白细胞增多症作为 COVID-19 的简单预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d9421e3474e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302400, encodeId=827b13024003e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！, objectType=article, longId=217212, objectId=a44c21e21243, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a44c21e21243, replyNumber=0, likeNumber=71, createdTime=2021-09-18, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a44c21e21243, moduleTitle=Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a44c21e21243)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302399, encodeId=19a0130239951, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Allergol Immunopathol (Madr)：过敏性鼻炎严重度与中性粒细胞/淋巴细胞、嗜酸性粒细胞/中性粒细胞和嗜酸性粒细胞/淋巴细胞比率的关系 , objectType=article, longId=217186, objectId=eaf921e186fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaf921e186fa, replyNumber=0, likeNumber=66, createdTime=2021-09-17, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaf921e186fa, moduleTitle=Allergol Immunopathol (Madr)：过敏性鼻炎严重度与中性粒细胞/淋巴细胞、嗜酸性粒细胞/中性粒细胞和嗜酸性粒细胞/淋巴细胞比率的关系 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaf921e186fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302398, encodeId=81311302398b1, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=CID：心脏移植受者移植后一个月淋巴细胞减少与感染结果或死亡的关系, objectType=article, longId=217092, objectId=9d1d21e09203, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d1d21e09203, replyNumber=0, likeNumber=75, createdTime=2021-09-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d1d21e09203, moduleTitle=CID：心脏移植受者移植后一个月淋巴细胞减少与感染结果或死亡的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d1d21e09203)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302397, encodeId=d704130239e17, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Leukemia：急性淋巴细胞白血病的内皮功能障碍和血栓栓塞相关生物标志物鉴定, objectType=article, longId=216773, objectId=285d216e73b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=285d216e73b0, replyNumber=0, likeNumber=70, createdTime=2021-09-08, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=285d216e73b0, moduleTitle=Leukemia：急性淋巴细胞白血病的内皮功能障碍和血栓栓塞相关生物标志物鉴定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=285d216e73b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302396, encodeId=773c13023969b, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Med：肿瘤浸润淋巴细胞（TIL）治疗：转移性肺癌的潜在治疗策略, objectType=article, longId=215867, objectId=2da821586e63, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2da821586e63, replyNumber=0, likeNumber=98, createdTime=2021-08-18, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2da821586e63, moduleTitle=Nat Med：肿瘤浸润淋巴细胞（TIL）治疗：转移性肺癌的潜在治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2da821586e63)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302395, encodeId=ca44130239514, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Med：抗PD-1耐药转移性肺癌患者肿瘤浸润淋巴细胞治疗效果何如？, objectType=article, longId=215717, objectId=cc41215e1761, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc41215e1761, replyNumber=0, likeNumber=109, createdTime=2021-08-15, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc41215e1761, moduleTitle=Nat Med：抗PD-1耐药转移性肺癌患者肿瘤浸润淋巴细胞治疗效果何如？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc41215e1761)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302394, encodeId=07971302394cb, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Leukemia：CXCR4的过度激活驱动慢性淋巴细胞白血病的发生发展, objectType=article, longId=215571, objectId=44ee2155e156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44ee2155e156, replyNumber=0, likeNumber=94, createdTime=2021-08-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44ee2155e156, moduleTitle=Leukemia：CXCR4的过度激活驱动慢性淋巴细胞白血病的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44ee2155e156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302393, encodeId=fa571302393ed, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Clin Cancer Res：Clever-1抗体可诱导淋巴细胞激活发挥抗肿瘤作用, objectType=article, longId=215431, objectId=1a23215431c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a23215431c9, replyNumber=0, likeNumber=66, createdTime=2021-08-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a23215431c9, moduleTitle=Clin Cancer Res：Clever-1抗体可诱导淋巴细胞激活发挥抗肿瘤作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a23215431c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302392, encodeId=f922130239239, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！, objectType=article, longId=215210, objectId=517621521090, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=517621521090, replyNumber=0, likeNumber=101, createdTime=2021-08-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=517621521090, moduleTitle=J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=517621521090)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302391, encodeId=a5821302391a1, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, objectType=article, longId=215018, objectId=3aeb21501886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3aeb21501886, replyNumber=0, likeNumber=67, createdTime=2021-07-31, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3aeb21501886, moduleTitle=J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3aeb21501886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302390, encodeId=f4ab1302390c6, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发, objectType=article, longId=214726, objectId=0cd1214e26c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cd1214e26c8, replyNumber=0, likeNumber=88, createdTime=2021-07-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cd1214e26c8, moduleTitle=Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cd1214e26c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302389, encodeId=cef5130238993, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）, objectType=article, longId=214041, objectId=ca9121404105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca9121404105, replyNumber=0, likeNumber=53, createdTime=2021-07-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca9121404105, moduleTitle=J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca9121404105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302388, encodeId=6a9a13023881f, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=DCR:淋巴细胞与 C 反应蛋白的比率是转移性结直肠癌患者中最敏感的预后指标, objectType=article, longId=213570, objectId=0ce12135e079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ce12135e079, replyNumber=0, likeNumber=80, createdTime=2021-07-02, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ce12135e079, moduleTitle=DCR:淋巴细胞与 C 反应蛋白的比率是转移性结直肠癌患者中最敏感的预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ce12135e079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302387, encodeId=06ea130238ecb, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Br J Cancer：中性粒细胞淋巴细胞比值NLR在肝细胞癌中的预后和诊断意义, objectType=article, longId=212793, objectId=f8b4212e9393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8b4212e9393, replyNumber=0, likeNumber=78, createdTime=2021-06-17, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8b4212e9393, moduleTitle=Br J Cancer：中性粒细胞淋巴细胞比值NLR在肝细胞癌中的预后和诊断意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8b4212e9393)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

AJH：治疗和未治疗的慢性淋巴细胞白血病患者的第二原发恶性肿瘤发生率对比

2021-10-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Prostate：淋巴细胞与单核细胞比例可预测临床显著性前列腺癌

2021-10-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后

2021-10-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

HAEMATOLOGICA：接受阿卡拉布替尼单药治疗的慢性淋巴细胞白血病患者的心血管不良事件: 762例患者的汇总分析。

2021-10-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nature Communications：脂肪细胞破坏急性淋巴细胞白血病的转化程序，有利于肿瘤的存活和持久性

2021-09-22

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

INT J LAB HEMATO：外周颗粒状淋巴细胞减少症和畸形白细胞增多症作为 COVID-19 的简单预后标志物

2021-09-21

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Oncol：慢性淋巴细胞白血病三联一线疗法：Acalabrutinib+Venetoclax+Obinutuzumab！

2021-09-18

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Allergol Immunopathol (Madr)：过敏性鼻炎严重度与中性粒细胞/淋巴细胞、嗜酸性粒细胞/中性粒细胞和嗜酸性粒细胞/淋巴细胞比率的关系

2021-09-17

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

CID：心脏移植受者移植后一个月淋巴细胞减少与感染结果或死亡的关系

2021-09-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Leukemia：急性淋巴细胞白血病的内皮功能障碍和血栓栓塞相关生物标志物鉴定

2021-09-08

智者为医08 (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Med：肿瘤浸润淋巴细胞（TIL）治疗：转移性肺癌的潜在治疗策略

2021-08-18

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Med：抗PD-1耐药转移性肺癌患者肿瘤浸润淋巴细胞治疗效果何如？

2021-08-15

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Leukemia：CXCR4的过度激活驱动慢性淋巴细胞白血病的发生发展

2021-08-12

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Clin Cancer Res：Clever-1抗体可诱导淋巴细胞激活发挥抗肿瘤作用

2021-08-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！

2021-08-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

J Hematol Oncol：塞利尼索(selinexor)治疗复发/难治性弥漫大B淋巴细胞瘤的疗效：SADAL研究

2021-07-31

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Cancer：化疗和错配修复缺陷协同促进TP53突变的发生和急性淋巴细胞白血病的复发

2021-07-25

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）

2021-07-12

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

DCR:淋巴细胞与 C 反应蛋白的比率是转移性结直肠癌患者中最敏感的预后指标

2021-07-02

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Br J Cancer：中性粒细胞淋巴细胞比值NLR在肝细胞癌中的预后和诊断意义

2021-06-17

科室
- - 订阅+
  - 更多科室
工具
服务